| Name | Title | Contact Details |
|---|
Statewide Distributors Inc is a Metairie, LA-based company in the Business Services sector.
Snider Law Firm Ltd is a Minneapolis, MN-based company in the Business Services sector.
JSI Janitorial is a prominent commercial janitorial service provider based in Cleveland, Ohio, established in 1970. The company employs nearly 1,000 staff members and serves over 275 clients across the state, including many Fortune 500 companies and prestigious office complexes. JSI specializes in high-quality, cost-effective building cleaning solutions, emphasizing environmental sustainability and innovative technology. The company offers a wide range of janitorial services tailored to various client needs, including daily and nightly cleaning, porter maintenance, hard surface floor care, carpet cleaning, hospital-grade operating room cleaning, construction cleanup, pressure washing, and window washing. JSI serves diverse industries such as healthcare, education, automotive, manufacturing, retail, government, and large office complexes. JSI is dedicated to delivering efficient janitorial services that promote clean, safe, and environmentally friendly buildings. The company focuses on innovation, sustainability, and advanced cleaning technologies while maintaining a skilled workforce through ongoing education and teamwork. JSI is recognized for its strong customer relationships and reliability, making it a trusted partner for many organizations.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
Join the YMCA for youth sports, swim lessons, gyms and group fitness classes, family programs, child care, social programs and much more.